| A guide to antigen processing and presentation N Pishesha, TJ Harmand, HL Ploegh Nature Reviews Immunology 22 (12), 751-764, 2022 | 436 | 2022 |
| One-pot dual labeling of IgG 1 and preparation of C-to-C fusion proteins through a combination of sortase A and butelase 1 TJ Harmand, D Bousbaine, A Chan, X Zhang, DR Liu, JP Tam, HL Ploegh Bioconjugate chemistry 29 (10), 3245-3249, 2018 | 102 | 2018 |
| Site-specific sequential protein labeling catalyzed by a single recombinant ligase FBH Rehm, TJ Harmand, K Yap, T Durek, DJ Craik, HL Ploegh Journal of the American Chemical Society 141 (43), 17388-17393, 2019 | 90 | 2019 |
| Exploring cellular biochemistry with nanobodies RW Cheloha, TJ Harmand, C Wijne, TU Schwartz, HL Ploegh Journal of Biological Chemistry 295 (45), 15307-15327, 2020 | 82 | 2020 |
| Protein chemical synthesis by α-ketoacid-hydroxylamine ligation. TJ Harmand, CE Murar, JW Bode Nature protocols 11 (6), 1130-1147, 2016 | 44 | 2016 |
| Nanobodies as in vivo, non-invasive, imaging agents TJ Harmand, A Islam, N Pishesha, HL Ploegh RSC Chemical Biology 2 (3), 685-701, 2021 | 40 | 2021 |
| New chemistries for chemoselective peptide ligations and the total synthesis of proteins TJR Harmand, CE Murar, JW Bode Current opinion in chemical biology 22, 115-121, 2014 | 39 | 2014 |
| Chemical synthesis of the highly hydrophobic antiviral membrane‐associated protein IFITM3 and modified variants TJ Harmand, VR Pattabiraman, JW Bode Angewandte Chemie International Edition 56 (41), 12639-12643, 2017 | 35 | 2017 |
| Induction of antigen-specific tolerance by nanobody–antigen adducts that target class-II major histocompatibility complexes N Pishesha, T Harmand, LY Smeding, W Ma, LS Ludwig, R Janssen, ... Nature Biomedical Engineering 5 (11), 1389-1401, 2021 | 32 | 2021 |
| A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants N Pishesha, TJ Harmand, PW Rothlauf, P Praest, RK Alexander, ... Proceedings of the National Academy of Sciences 118 (44), e2116147118, 2021 | 27 | 2021 |
| Asparaginyl ligase-catalyzed one-step cell surface modification of red blood cells TJ Harmand, N Pishesha, FBH Rehm, W Ma, WB Pinney, YJ Xie, ... ACS Chemical Biology 16 (7), 1201-1207, 2021 | 23 | 2021 |
| Converting an anti-mouse CD4 monoclonal antibody into an scFv positron emission tomography imaging agent for longitudinal monitoring of CD4+ T cells A Islam, N Pishesha, TJ Harmand, H Heston, AW Woodham, RW Cheloha, ... The Journal of Immunology 207 (5), 1468-1477, 2021 | 14 | 2021 |
| Improved synthesis of (S)-N-Boc-5-oxaproline for protein synthesis with the α-ketoacid-hydroxylamine (KAHA) ligation CE Murar, TJ Harmand, JW Bode Bioorganic & medicinal chemistry 25 (18), 4996-5001, 2017 | 10 | 2017 |
| Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms N Pishesha, T Harmand, C Carpenet, X Liu, A Bhan, A Islam, ... Proceedings of the National Academy of Sciences 119 (43), e2211065119, 2022 | 9 | 2022 |
| Optimized synthesis of a cyanosulfurylide linker for Fmoc-SPPS of C-terminal peptide α-ketoacids TJ Harmand, SS Kulkarni, JW Bode Tetrahedron Letters 56 (23), 3477-3480, 2015 | 9 | 2015 |
| Preparation of (S)-N-Boc-5-oxaproline CE Murar, TJ Harmand, H Takano, JW Bode Organic Syntheses 95, 157-176, 2018 | 3 | 2018 |
| Enantioselective Synthesis of (S)-Ethyl 2-((tert-butoxycarbonyl)((tert-butyldimethylsilyl)oxy)amino)-4-oxobutanoate TJ Harmand, CE Murar, H Takano, JW Bode Organic Syntheses 95, 142-156, 2018 | 1 | 2018 |
| Imaging the immune sequelae of infection with SARS‐CoV‐2 in nonhuman primates by using two nanobody PET‐tracers G Koopman, T Verhoeven, P Mooij, RF Acar, T Harmand, L Flanagan, ... Journal of Medical Virology 96 (10), e29956, 2024 | | 2024 |
| Nanobody (vhh) conjugates and uses there of N Pishesha, HL Ploegh, T Harmand US Patent App. 18/007,638, 2023 | | 2023 |
| (S)‐2‐(tert‐Butoxycarbonyl)‐isoxazolidine‐3‐carboxylic acid C Murar, TJ Harmand Encyclopedia of Reagents for Organic Synthesis, 1-2, 2018 | | 2018 |
